<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04010409</url>
  </required_header>
  <id_info>
    <org_study_id>201809069RINA</org_study_id>
    <nct_id>NCT04010409</nct_id>
  </id_info>
  <brief_title>Mindreading in Adults With Autism Spectrum Disorder</brief_title>
  <official_title>Mindreading in Adults With Autism Spectrum Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to investigate the ability of reading emotions by the Eyes task in adults
      with ASD, and examine the gazing pattern and frontal activation during the task. We plan to
      recruit 50 adults with ASD and 50 typically-developing adults. Eye-tracking and frontal
      activation (measured by functional near-infrared spectroscopy) will be examined during the
      Eyes task.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Autism spectrum disorder (ASD) is a clinical syndrome characterized by mindreading deficits,
      or Theory of Mind deficits. The Reading the Mind in the Eyes task (abbreviated as the Eyes
      task) was developed to assess the mindreading deficits as a hallmark of social deficits of
      ASD. This study aims to investigate the ability of reading emotions by the Eyes task in
      adults with ASD, and examine the gazing pattern and frontal activation during the task. We
      plan to recruit 50 adults with ASD and 50 typically-developing adults. All the participants
      will complete clinical measures and the Eyes task. Eye-tracking and frontal activation
      (measured by functional near-infrared spectroscopy) will be examined during the Eyes task.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 8, 2019</start_date>
  <completion_date type="Anticipated">November 2019</completion_date>
  <primary_completion_date type="Anticipated">November 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>eye tracking indicators</measure>
    <time_frame>30 min</time_frame>
    <description>eye tracking indicators</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Autism Spectrum Disorder</condition>
  <arm_group>
    <arm_group_label>ASD Group</arm_group_label>
    <description>Autism spectrum disorder participants, no intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TD Group</arm_group_label>
    <description>Typically developmental controls,no intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>no intervention</intervention_name>
    <description>no intervention</description>
    <arm_group_label>ASD Group</arm_group_label>
    <arm_group_label>TD Group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The 30 adults with ASD will be recruited from Adult ASD clinics in Department of
        Psychiatry, National Taiwan University Hospital.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult aged between 20 and 50 years who had a diagnosis of ASD based on DSM-5.

          -  Had a full-scale IQ &gt; 70 on WAIS-IV.

        Exclusion Criteria:

          -  A history of major mental illness (e.g., bipolar affective disorder, schizophrenia) or
             neurological diseases.

          -  Visual impairment and that would preclude participation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yi Ling Chien, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Taiwan University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yi Ling Chien, M.D., Ph.D.</last_name>
    <phone>886-2-2312-3456</phone>
    <phone_ext>66013</phone_ext>
    <email>ylchien@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yi Ling Chien, M.D., Ph.D.</last_name>
      <phone>886-2-2312-3456</phone>
      <phone_ext>66013</phone_ext>
      <email>ylchien@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>December 2018</verification_date>
  <study_first_submitted>July 4, 2019</study_first_submitted>
  <study_first_submitted_qc>July 4, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 8, 2019</study_first_posted>
  <last_update_submitted>July 4, 2019</last_update_submitted>
  <last_update_submitted_qc>July 4, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 8, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Autistic Disorder</mesh_term>
    <mesh_term>Autism Spectrum Disorder</mesh_term>
    <mesh_term>Child Development Disorders, Pervasive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

